Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China

BACKGROUND: Lenvatinib has become an indispensable part of treatment regimens for patients with advanced hepatocellular carcinoma (aHCC). Several recent real-world studies appear to have confirmed this; however, there are etiological differences. This necessitates further real-world studies of lenva...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dong-Xu, Yang, Xu, Lin, Jian-Zhen, Bai, Yi, Long, Jun-Yu, Yang, Xiao-Bo, Seery, Samuel, Zhao, Hai-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438196/
https://www.ncbi.nlm.nih.gov/pubmed/32874058
http://dx.doi.org/10.3748/wjg.v26.i30.4465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438196/
https://www.ncbi.nlm.nih.gov/pubmed/32874058
http://dx.doi.org/10.3748/wjg.v26.i30.4465

Ejemplares similares